Can occupational exposure to brake‑fluid chemicals, fuels, and degreasers cause atrial fibrillation?

Occupational Exposure to Brake Fluid, Fuels, and Degreasers Can Cause Atrial Fibrillation

Yes, occupational exposure to brake fluid chemicals, fuels, and degreasers can cause atrial fibrillation, particularly with halogenated hydrocarbons and organic solvents commonly found in these products.

Direct Evidence Linking Solvents to Atrial Fibrillation

The strongest evidence comes from documented cases of atrial fibrillation directly caused by occupational solvent exposure. Workers exposed to trifluorotrichloroethane (CFC 113)—a common degreasing agent—developed atrial fibrillation and sudden cardiac death 1. This halogenated hydrocarbon and related compounds are widely used in brake fluid formulations and industrial degreasers.

Mechanism of Arrhythmogenesis

These chemicals cause cardiac arrhythmias through:

• Direct myocardial sensitization to catecholamines
• Disruption of cardiac ion channels affecting atrial electrical stability
• Autonomic nervous system imbalance triggering arrhythmia initiation 2

Broader Solvent Exposure Evidence

A comprehensive study of 500 workers in solvent and paint production lines demonstrated significantly increased electrocardiographic abnormalities, with arrhythmia risk elevated 1.15-fold (95% CI: 1.08-1.49) compared to unexposed workers 2. The study specifically identified:

• Supraventricular ectopic beats (most common)
• Conduction defects
• Repolarization disturbances
• P wave abnormalities (relative risk 1.02,95% CI: 1.01-2.28)

Workers exposed to benzene and xylene—components frequently found in fuels and degreasers—showed 30.51% prevalence of cardiovascular abnormalities (OR = 2.44; 95% CI 1.24-4.85) with significant correlation between length of service and cardiovascular effects 3.

Specific Chemical Culprits in These Products

Brake Fluid Components

• Glycol ethers
• Polyalkylene glycols
• Halogenated hydrocarbons (in older formulations)

Fuel Components

• Benzene
• Xylene
• Polycyclic aromatic hydrocarbons
• Volatile organic compounds

Degreaser Components

• Trifluorotrichloroethane (CFC 113)
• Trichloroethylene
• Perchloroethylene
• Other halogenated solvents

Clinical Recognition Algorithm

When evaluating a patient with new-onset atrial fibrillation:

1. Obtain detailed occupational history focusing on:

   • Chronological summary of all work activities and duration
   • Specific chemicals present in workplace (obtain Safety Data Sheets if possible)
   • Ventilation systems and protective equipment use
   • Whether coworkers have similar symptoms 4

2. Assess temporal relationship:

   • Onset of AF relative to exposure periods
   • Pattern of paroxysmal episodes correlating with work shifts
   • Resolution or improvement during time away from work

3. Rule out confounding factors:

   • Traditional AF risk factors (hypertension, diabetes, coronary disease, age)
   • Non-occupational chemical exposures
   • Drug-induced causes 5

4. Document exposure intensity:

   • Years of exposure
   • Daily exposure duration
   • Adequacy of workplace monitoring and protective measures 4

Critical Caveats

The temporal relationship may not always be immediate. Unlike acute poisoning scenarios where AF appears within hours of exposure 6, chronic occupational exposure can create an arrhythmogenic substrate over months to years through mechanisms like:

• Myocardial fibrosis development
• Autonomic dysfunction
• Systemic inflammation 2, 3

Absence of abnormal liver enzymes does not exclude toxicity. Workers with solvent-induced cardiovascular effects may have normal aminotransferases despite significant cardiac involvement 4.

Management Implications

Immediate removal from exposure is the primary intervention. Case reports demonstrate spontaneous return to sinus rhythm within 24 hours of exposure cessation 6. For established AF:

• Standard anticoagulation based on CHA₂DS₂-VASc score applies
• Rate or rhythm control as clinically indicated
• Workplace modification is mandatory to prevent recurrence and progression
• Consider reporting to occupational health authorities for workplace investigation 4

Prognosis and Prevention

The prognosis depends on exposure duration and whether removal from exposure occurs before irreversible myocardial remodeling. Early-stage, exposure-related AF may resolve completely with exposure cessation, while chronic exposure can lead to persistent AF requiring ongoing management.

Prevention requires engineering controls (adequate ventilation, enclosed systems), administrative controls (exposure time limits, rotation schedules), and personal protective equipment (respirators, not just gloves) 4. Standard occupational exposure limits may not protect all workers from cardiovascular effects 4.